Eone Diagnomics Genome Center Co Ltd
KOSDAQ:245620
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Eone Diagnomics Genome Center Co Ltd
Other Current Assets
Eone Diagnomics Genome Center Co Ltd
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
Eone Diagnomics Genome Center Co Ltd
KOSDAQ:245620
|
Other Current Assets
₩696.8m
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Other Current Assets
₩149.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
|
A
|
ADM Korea Inc
KOSDAQ:187660
|
Other Current Assets
₩1.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Other Current Assets
₩1.4B
|
CAGR 3-Years
-29%
|
CAGR 5-Years
8%
|
CAGR 10-Years
29%
|
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Other Current Assets
₩10.7B
|
CAGR 3-Years
12%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Other Current Assets
₩8.9B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
25%
|
|
Eone Diagnomics Genome Center Co Ltd
Glance View
EONE DIAGNOMICS GENOME CENTER Co., Ltd. engages in the operation as a genomics company providing a range of clinical and consumer genetic services. The company is headquartered in Incheon, Incheon. The company went IPO on 2018-06-26. The firm is engaged in non-invasive prenatal tests (NIPT), newborn screening tests, ophthalmologist specialist genome analysis tests, customized disease prediction tests, and direct to consumer (DTC) genetic tests, among others. In addition, the Company is developing genome-related software.
See Also
What is Eone Diagnomics Genome Center Co Ltd's Other Current Assets?
Other Current Assets
696.8m
KRW
Based on the financial report for Sep 30, 2025, Eone Diagnomics Genome Center Co Ltd's Other Current Assets amounts to 696.8m KRW.
What is Eone Diagnomics Genome Center Co Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
-40%
Over the last year, the Other Current Assets growth was -64%. The average annual Other Current Assets growth rates for Eone Diagnomics Genome Center Co Ltd have been -47% over the past three years , -40% over the past five years .
